NEO-MERCAZOLE

This brand name is authorized in Australia, France, Ireland, New Zealand.

Active ingredients

The drug NEO-MERCAZOLE contains one active pharmaceutical ingredient (API):

1	Carbimazole UNII 8KQ660G60G - CARBIMAZOLE
	Carbimazole, a thionamide, is a pro-drug which undergoes rapid and virtually complete metabolism to the active metabolite, thiamazole, also known as methimazole. The method of action is believed to be inhibition of the organification of iodide and the coupling of iodothyronine residues which in turn suppress the synthesis of thyroid hormones.
	Read more about Carbimazole

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
NEOMERCAZOLE Tablet	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
H03BB01	Carbimazole	H Systemic hormonal preparations, excl. Sex hormones and insulins → H03 Thyroid therapy → H03B Antithyroid preparations → H03BB Sulfur-containing imidazole derivatives
Discover more medicines within H03BB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	1153Q
FR	Base de données publique des médicaments	61451683, 63839179
IE	Health Products Regulatory Authority	36080, 39403
NZ	Medicines and Medical Devices Safety Authority	2119